These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19002718)

  • 21. A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE.
    Liu NF; Yu Z; Luo Y; Sun D; Yan Z
    Lymphology; 2015 Jun; 48(2):93-6. PubMed ID: 26714373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compound heterozygosity for a variably penetrant variant and a variant of unknown significance in FLT4 causes fully penetrant Milroy's lymphedema.
    Kim J; Lim SY
    Lymphology; 2022; 55(2):41-46. PubMed ID: 36170577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Milroy disease and the VEGFR-3 mutation phenotype.
    Brice G; Child AH; Evans A; Bell R; Mansour S; Burnand K; Sarfarazi M; Jeffery S; Mortimer P
    J Med Genet; 2005 Feb; 42(2):98-102. PubMed ID: 15689446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.
    Irrthum A; Karkkainen MJ; Devriendt K; Alitalo K; Vikkula M
    Am J Hum Genet; 2000 Aug; 67(2):295-301. PubMed ID: 10856194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.
    Mizuno S; Yamada Y; Yamada K; Nomura N; Wakamatsu N
    Congenit Anom (Kyoto); 2005 Jun; 45(2):59-61. PubMed ID: 15904433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation on the role of biallelic variants in VEGF-C found in a patient affected by Milroy-like lymphedema.
    Mukenge S; Jha SK; Catena M; Manara E; Leppänen VM; Lenti E; Negrini D; Bertelli M; Brendolan A; Jeltsch M; Aldrighetti L
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1389. PubMed ID: 32592340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygous deletion of the VEGFC gene in 4q34.3 is associated with Milroy-like lymphedema: First prenatal case report.
    Huynh MT; Degre S; Joly-Helas G; Bréon C; Potel S; Chambon P; Bouligand J; Layet V
    Am J Med Genet A; 2022 Dec; 188(12):3550-3554. PubMed ID: 36129367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic dysfunction, not aplasia, underlies Milroy disease.
    Mellor RH; Hubert CE; Stanton AW; Tate N; Akhras V; Smith A; Burnand KG; Jeffery S; Mäkinen T; Levick JR; Mortimer PS
    Microcirculation; 2010 May; 17(4):281-96. PubMed ID: 20536741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of FLT4 mutations associated with Nonne-Milroy lymphedema.
    Verstraeten VL; Holnthoner W; van Steensel MA; Veraart JC; Bladergroen RS; Heckman CA; Keskitalo S; Frank J; Alitalo K; van Geel M; Steijlen PM
    J Invest Dermatol; 2009 Feb; 129(2):509-12. PubMed ID: 18719607
    [No Abstract]   [Full Text] [Related]  

  • 30. De novo novel splice-site mutation in FLT4/VEGFR3 is associated with Milroy disease.
    Shibata Y; Okamoto T; Saruta T; Matsuoka F; Fujieda M; Sano S
    J Dermatol; 2021 Jan; 48(1):e26-e28. PubMed ID: 32991753
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic Screening in a Large Cohort of Italian Patients Affected by Primary Lymphedema Using a Next Generation Sequencing (NGS) Approach.
    Michelini S; Vettori A; Maltese PE; Cardone M; Bruson A; Fiorentino A; Cappellino F; Sainato V; Guerri G; Marceddu G; Tezzele S; Bertelli M
    Lymphology; 2016 Jun; 49(2):57-72. PubMed ID: 29906362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antenatal presentation of hereditary lymphedema type I.
    Boudon E; Levy Y; Abossolo T; Cartault F; Brouillard P; Vikkula M; Kieffer-Traversier M; Ramful D; Alessandri JL
    Eur J Med Genet; 2015; 58(6-7):329-31. PubMed ID: 25896638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and genetic study of 46 Italian patients with primary lymphedema.
    Michelini S; Degiorgio D; Cestari M; Corda D; Ricci M; Cardone M; Mander A; Famoso L; Contini E; Serrani R; Pinelli L; Cecchin S; Bertelli M
    Lymphology; 2012 Mar; 45(1):3-12. PubMed ID: 22768468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two novel variations p.(Ser1275Thr) and p.(Ser1275Arg) in FLT4 causing prenatal hereditary lymphedema type 1.
    Lajmi Y; Loeuillet L; Petrilli G; Egloff C; Nectoux J; Molac C; Roux N; Pannier E; Achaiaa A; Arkoub ZA; Chuon S; Coussement A; Dupont JM; Malan V; Spaggiari E; Razavi F; Amiel J; Bessières B; Grotto S; Attié-Bitach T
    Birth Defects Res; 2023 Mar; 115(5):563-571. PubMed ID: 36538874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema.
    Evans AL; Bell R; Brice G; Comeglio P; Lipede C; Jeffery S; Mortimer P; Sarfarazi M; Child AH
    J Med Genet; 2003 Sep; 40(9):697-703. PubMed ID: 12960217
    [No Abstract]   [Full Text] [Related]  

  • 36. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis.
    Le Guen L; Karpanen T; Schulte D; Harris NC; Koltowska K; Roukens G; Bower NI; van Impel A; Stacker SA; Achen MG; Schulte-Merker S; Hogan BM
    Development; 2014 Mar; 141(6):1239-49. PubMed ID: 24523457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.
    Irrthum A; Devriendt K; Chitayat D; Matthijs G; Glade C; Steijlen PM; Fryns JP; Van Steensel MA; Vikkula M
    Am J Hum Genet; 2003 Jun; 72(6):1470-8. PubMed ID: 12740761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia-lymphedema syndrome 3.
    Brouillard P; Dupont L; Helaers R; Coulie R; Tiller GE; Peeden J; Colige A; Vikkula M
    Hum Mol Genet; 2017 Nov; 26(21):4095-4104. PubMed ID: 28985353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-128-3p directly targets VEGFC/VEGFR3 to modulate the proliferation of lymphatic endothelial cells through Ca
    Zhou J; He Z; Guo L; Zeng J; Liang P; Ren L; Zhang M; Zhang P; Huang X
    Int J Biochem Cell Biol; 2018 Sep; 102():51-58. PubMed ID: 29777777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.
    Karkkainen MJ; Ferrell RE; Lawrence EC; Kimak MA; Levinson KL; McTigue MA; Alitalo K; Finegold DN
    Nat Genet; 2000 Jun; 25(2):153-9. PubMed ID: 10835628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.